# REward Processing And Citalopram Study

> **NCT06017037** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Oxford** · enrollment: 40 (estimated)

## Conditions studied

- Anhedonia

## Interventions

- **DRUG:** Citalopram 20mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06017037
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-19
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06017037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06017037, "REward Processing And Citalopram Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06017037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*